Pendapatan operasional sadurunge ngurangi amortisasi: Alto Neuroscience Inc (ANRO)

This chart on the GURU.Markets platform utilizes an EBITDA snapshot to visualize the battle between traders for capital, while 0.00 records the magnitude of this parameter. Alto Neuroscience, Inc. (ANRO) integrates bioethics and ESG principles into the development of neuropsychiatric drugs. Proven logistics operators guarantee supply chain continuity. However, intense competition within the psychiatry sector and the risk of scientific failures present significant challenges for the business.

Bathi operasional EBITDA Alto Neuroscience, Inc. (ANRO): kanggo periode 23.11.2025 - 12.11.2026

Ringkesan rincian data analitis Alto Neuroscience (ANRO)

- rega saham lan konsensus proyeksi valuasi:

Bagan kutipan Alto Neuroscience Corp|ANRO - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Alto Neuroscience|ANRO - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Aset Bersih saben Saham Alto Neuroscience|ANRO - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih altoneuroscience.com|ANRO - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Alto Neuroscience, Inc.|ANRO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Alto Neuroscience Inc|ANRO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Alto Neuroscience|ANRO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Alto Neuroscience|Rasio likuiditas perantara altoneuroscience.com

- rincian bathi lan kelipatan pasar:

ANRO - Bathi resik perusahaan|Bathi resik sing dikarepake Alto Neuroscience, Inc.|ANRO - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi altoneuroscience.com|ANRO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Alto Neuroscience|ANRO - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Alto Neuroscience|ANRO - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan altoneuroscience.com|ANRO - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Alto Neuroscience, Inc.

Ringkesan analitik perusahaan:ANRO (Alto Neuroscience Corp)

Alto Neuroscience, Inc. (ANRO) automates therapy selection through AI-driven biomarker analysis, which directly impacts operational cost efficiency. Historical EBITDA_Co data reflects daily cash flow from core operations, demonstrating the business's ability to generate value net of depreciation and amortization. The trend of this metric allows investors to assess the fundamental stability of Alto Neuroscience, Inc. (ANRO) and the scaling pace of its digital healthcare solutions.

Pesaing Alto Neuroscience, Inc. (ANRO)